Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27858855 | 0.82 | PPARD (0.36) | PPARDTSHRTP53TDP1NR1I2 | |
| SCHEMBL1030662 | 0.82 | PPARD (0.38) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL5030295 | 0.80 | GLO1 (0.42) | PPARDTSHRNPSR1ALDH1A1LMNA | |
| SCHEMBL10497587 | 0.80 | TSHR (0.37) | PPARDTSHRTP53TDP1NR1I2 | |
| SCHEMBL11336903 | 0.78 | TSHR (0.43) | PPARDTSHRTP53TDP1NR1I2 | |
| SCHEMBL10497445 | 0.76 | CETP (0.43) | — | |
| SCHEMBL12593697 | 0.72 | TSHR (0.39) | PPARDTSHRTP53TDP1NR1I2 | |
| SCHEMBL28358348 | 0.72 | TSHR (0.41) | PPARDTSHRTP53TDP1NR1I2 | |
| SCHEMBL8734587 | 0.72 | TSHR (0.41) | PPARDTSHRTP53TDP1NR1I2 | |
| SCHEMBL11347993 | 0.71 | TSHR (0.37) | PPARDTSHRTP53TDP1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111432891-B | Polymer containing phosphonyl-phosphate groups and anionic groups | 宝洁公司 | 2024-01-02 | — | — | CN | disclosed |
| US-11046817-B2 | Compositions comprising multi-valent cations and phosphono-phosphate containing polymers | THE PROCTER & GAMBLE COMPANY (US) | 2021-06-29 | — | — | US | disclosed |
| US-11008411-B2 | Phosphono-phosphate and anionic group containing polymers | THE PROCTER & GAMBLE COMPANY (US) | 2021-05-18 | — | — | US | disclosed |
| US-20210047475-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONO-PHOSPHATE AND ANIONIC GROUP CONTAINING POLYMERS | PROCTER & GAMBLE (US) | 2021-02-18 | — | — | US | disclosed |
| CN-111447974-A | Oral care compositions comprising polymers containing phosphono-phosphate groups and anionic groups | 宝洁公司 | 2020-07-24 | — | — | CN | disclosed |
| CN-111432891-A | Polymers containing phosphono-phosphate groups and anionic groups | 宝洁公司 | 2020-07-17 | — | — | CN | disclosed |
| CN-111372554-A | Compositions comprising multivalent cations and phosphono-phosphate-containing polymers | 宝洁公司 | 2020-07-03 | — | — | CN | disclosed |
| CN-111372657-A | Phosphonyl-phosphate containing compounds and polymers | 宝洁公司 | 2020-07-03 | — | — | CN | disclosed |
| US-20190177489-A1 | Compositions Comprising Multi-valent Cations and Phosphono-phosphate Containing Polymers | THE PROCTER & GAMBLE COMPANY | 2019-06-13 | — | — | US | disclosed |
| US-20190177490-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONO-PHOSPHATE AND ANIONIC GROUP CONTAINING POLYMERS | THE PROCTER & GAMBLE COMPANY | 2019-06-13 | — | — | US | disclosed |
| US-20190177451-A1 | Phosphono-Phosphate And Anionic Group Containing Polymers | THE PROCTER & GAMBLE COMPANY | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190177451-A1 | Phosphono-Phosphate And Anionic Group Containing Polymers | PHOSPHO1, PHPT1, ACP1 | PPARD 4414/4885TSHR 3710/4885TP53 2680/4885 |
| US-20210047475-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONO-PHOSPHATE AND ANIONIC GROUP CONTAINING POLYMERS | PHOSPHO1, PHPT1, INPP5D | PPARD 4093/4885TSHR 4586/4885TP53 1350/4885 |
| US-11008411-B2 | Phosphono-phosphate and anionic group containing polymers | PHOSPHO1, PHPT1, ACP1 | PPARD 4414/4885TSHR 3710/4885TP53 2680/4885 |
| US-11046817-B2 | Compositions comprising multi-valent cations and phosphono-phosphate containing polymers | PHOSPHO1, INPP5D, PTEN | PPARD 4106/4885TSHR 4795/4885TP53 738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.